Grace Therapeutics
GRCE
8 hedge funds and large institutions have $8.53M invested in Grace Therapeutics in 2013 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.
667% more capital invested
Capital invested by funds: $1.11M → $8.53M (+$7.41M)
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
33% more funds holding
Funds holding: 6 → 8 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
+$7.23M |
| 2 |
IIM
Intact Investment Management
Montreal,
Quebec, Canada
|
+$2.73M |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.11M |
| 4 |
EEG
E.E. Geduld
|
+$42.6K |
| 5 |
EWM
Edge Wealth Management
New York
|
+$2.46K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$53K |
| 2 |
U
UBS
Zurich,
Switzerland
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $5.24M | +$7.23M | +8,823 | +2,740% |
|
|
IIM
2
Intact Investment Management
Montreal,
Quebec, Canada
| $2.08M | +$2.73M | +3,333 | New |
|
|
3
Bank of Montreal
Toronto,
Ontario, Canada
| $1.17M | +$1.11M | +1,354 | +226% |
|
|
EEG
4
E.E. Geduld
| $31K | +$42.6K | +52 | New |
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $3K | – | – | – |
|
|
EWM
6
Edge Wealth Management
New York
| $2K | +$2.46K | +3 | New |
|
7
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1K | – | – | – |
|
|
VKH
8
Virtu KCG Holdings
New York
| – | -$53K | -46 | Closed |
|
|
U
9
UBS
Zurich,
Switzerland
| – | -$5K | -5 | Closed |
|
10
Bank of America
Charlotte,
North Carolina
| – | +$819 | +1 | New |
|
GRCE Hedge Fund Activity: Q4 2013 in Review
8 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q4 2013, worth a combined $8.53M — up 667% from $1.11M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new GRCE positions and 2 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Perceptive Advisors, adding an estimated $7.23M. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $53K sold.
- 8 institutional investors held Grace Therapeutics (GRCE) as of Q4 2013, up from 6 in Q3 2013.
- Funds reported $8.53M of Grace Therapeutics stock for Q4 2013, up 667% quarter-over-quarter.
- 4 funds opened new Grace Therapeutics positions in Q4 2013 and 2 closed out, a net change of +2 holders.
- The largest Grace Therapeutics buyer in Q4 2013 was Perceptive Advisors, an estimated $7.23M added.
- The largest Grace Therapeutics seller in Q4 2013 was Virtu KCG Holdings, an estimated $53K sold.
Based on aggregated 13F filings for Q4 2013.